(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid

C48H60N6O4 — CID 142418870

IUPAC(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid
SMILESO=C(OC1CNc2nc(CCCCCC3CN([C@@H](C(=O)O)c4ccccc4)C3)ccc2C1)[C@H](c1ccccc1)N1CC(CCCCCc2ccc3c(n2)NCCC3)C1
InChIInChI=1S/C48H60N6O4/c55-47(56)43(36-16-7-3-8-17-36)53-30-34(31-53)14-5-1-12-22-41-26-24-39-28-42(29-50-46(39)52-41)58-48(57)44(37-18-9-4-10-19-37)54-32-35(33-54)15-6-2-11-21-40-25-23-38-20-13-27-49-45(38)51-40/h3-4,7-10,16-19,23-26,34-35,42-44H,1-2,5-6,11-15,20-22,27-33H2,(H,49,51)(H,50,52)(H,55,56)/t42?,43-,44+/m1/s1
InChIKeyQSUPHNKSAAIQHL-KGZJDIOZSA-N
MW785.05 g/mol
LogP8.05
Rot. Bonds19

About (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid

(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid (PubChem CID 142418870) has the molecular formula C48H60N6O4 and a molecular weight of 785.05 g/mol. Its IUPAC name is (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid.

Molecular Properties

Compound Name(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid
PubChem CID142418870
Molecular FormulaC48H60N6O4
Molecular Weight785.05 g/mol
Exact Mass784.47
IUPAC Name(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid
SMILESO=C(OC1CNc2nc(CCCCCC3CN([C@@H](C(=O)O)c4ccccc4)C3)ccc2C1)[C@H](c1ccccc1)N1CC(CCCCCc2ccc3c(n2)NCCC3)C1
InChIInChI=1S/C48H60N6O4/c55-47(56)43(36-16-7-3-8-17-36)53-30-34(31-53)14-5-1-12-22-41-26-24-39-28-42(29-50-46(39)52-41)58-48(57)44(37-18-9-4-10-19-37)54-32-35(33-54)15-6-2-11-21-40-25-23-38-20-13-27-49-45(38)51-40/h3-4,7-10,16-19,23-26,34-35,42-44H,1-2,5-6,11-15,20-22,27-33H2,(H,49,51)(H,50,52)(H,55,56)/t42?,43-,44+/m1/s1
InChIKeyQSUPHNKSAAIQHL-KGZJDIOZSA-N
XLogP8.05
TPSA119.92 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds19
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500785.05
LogP ≤ 58.05
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid?
The IUPAC name of (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid (CID 142418870) is (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid.
What is the SMILES notation for (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid?
The canonical SMILES for (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid is O=C(OC1CNc2nc(CCCCCC3CN([C@@H](C(=O)O)c4ccccc4)C3)ccc2C1)[C@H](c1ccccc1)N1CC(CCCCCc2ccc3c(n2)NCCC3)C1.
What is the InChIKey of (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid?
The InChIKey is QSUPHNKSAAIQHL-KGZJDIOZSA-N. The full InChI is InChI=1S/C48H60N6O4/c55-47(56)43(36-16-7-3-8-17-36)53-30-34(31-53)14-5-1-12-22-41-26-24-39-28-42(29-50-46(39)52-41)58-48(57)44(37-18-9-4-10-19-37)54-32-35(33-54)15-6-2-11-21-40-25-23-38-20-13-27-49-45(38)51-40/h3-4,7-10,16-19,23-26,34-35,42-44H,1-2,5-6,11-15,20-22,27-33H2,(H,49,51)(H,50,52)(H,55,56)/t42?,43-,44+/m1/s1.
What are the key properties of (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid?
(2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid has a molecular weight of 785.05 g/mol, XLogP of 8.05, 19 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-phenyl-2-[3-[5-[6-[(2S)-2-phenyl-2-[3-[5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentyl]azetidin-1-yl]acetyl]oxy-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]pentyl]azetidin-1-yl]acetic acid is sourced from PubChem (CID 142418870), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).